Pharmaceutical price controls have become a controversial political issue. Numerous federal and state legislators have proposed reducing pharmaceutical prices by various methods. President Clinton's proposed out-patient drug benefit for Medicare-with special mechanisms for negotiating drug prices--is expected to be one of the high-visibility legislative proposals Congress considers in this election year.
At this event, John E. Calfee will brief the press on the findings of his timely new study
Prices, Markets, and the Pharmaceutical Revolution (AEI, 2000). He will comment on rapidly rising pharmaceutical expenditures, the sources of the ongoing pharmaceutical research revolution, and the threat of price controls. He will also present reasonable solutions for Medicare coverage for pharmaceuticals.
EMAIL
PRINT
SAVE
